The 4 Stages of Learning

Mar 24, 2020 | Blog | 0 comments

Daniel Gigante

Due to the coronavirus pandemic, many in the workforce are either working remotely or not working at all. This has presented them with unforeseen challenges. One which might initially seem innocuous, but could lead to damaging psychological effects, is boredom. With that in mind, we wanted to encourage people to level-up in their lives — be it professionally or personally.

One way to level-up faster is to understand the art of learning. Our very own Andrew Satz decided to sit down and discuss the 4 stages of learning. See below.

The 4 stages are fairly simple: luck, avoiding failure, learning from failure, learning from success.

The biggest takeaway is the importance of the 4th stage. It’s far too common for us to achieve a desired outcome and never evaluate how we could have improved our performance. However, if we don’t iterate, if we don’t improve, our next attempt may not result in the same outcome.

We hope you find this information useful. We will try to provide articles and videos that aren’t directly related to our business, but instead offer tips to improve or level-up both professionally and personally. Particularly, during these difficult times.


Submit a Comment

Your email address will not be published. Required fields are marked *

Large Pharma’s Embrace of Artificial Intelligence

The benefits of computational drug development are well known and accepted by many in the pharmaceutical space. However, since the onset of the global pandemic, consensus went from it being an interesting concept that was almost certainly the future, to something we need implemented as soon as possible. This is one of the few silver linings of the coronavirus outbreak.

The depth, vision and progress of EVQLV

Our CEO, Andrew Satz, recently spoke at Columbia University School of General Studies’ “Alumni in Action.” The subject of his talk was artificial intelligence. One of the questions posed to Andrew was what we were doing outside of coronavirus, along with the long term plans of our company

EVQLV Applies Proprietary AI Technology in Collaboration with Twist Bioscience to Discover and Validate Novel Antibody Therapies

EVQLV, Inc., an artificial intelligence-enabled technology company accelerating biologics discovery, announced today a collaboration with Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, to discover novel antibody-based therapies.

EVQLV’s Evolutionary Algorithm Explained

Brett Averso (CTO, EVQLV) and Bhoomika Kumar (SciTech intern, EVQLV) teamed up to provide a high-level overview¬†of how EVQLV’s evolutionary algorithm works.

Andrew Satz on the Talent Finders Podcast

EVQLV’s CEO, Andrew Satz, joined Kerrin Black of the Talent Finders Podcast to discuss his entrepreneurial journey, some of the challenges facing AI for drug discovery, his legacy and much more.

Pin It on Pinterest